The United States gives full approval to the Pfizer vaccine

The US Food and Drug Administration has granted full approval for the use of the Pfizer vaccine against the emerging coronavirus (Covid-19) for people aged 16 years and over, in a step that is expected to pave the way for a series of decisions obligating people in the United States to be vaccinated with the spread of the mutated Delta there.

"The FDA's approval of this vaccine represents a step as we continue to respond to the COVID-19 pandemic," Acting FDA Commissioner Janet Woodcock said in a statement.

"While millions of people have safely received COVID-19 vaccines, we know that for some, FDA approval of the vaccine will increase confidence in the vaccine," she added.

Pfizer's vaccine, which may now be marketed under its brand name Komernati, is the first to gain full approval.

Tens of thousands of doses of it have been given so far under the emergency use permit he obtained on December 11, 2020.

The decision to grant approval is based on updated data from clinical trials, including longer follow-up, while its safety and efficacy have been evaluated in more than 40,000 people.

And the US military has previously announced that it will oblige its members to receive the vaccine as soon as it obtains full approval, while a series of private companies and universities are expected to take similar steps.

Follow our latest local and sports news and the latest political and economic developments via Google news